Therapies on a nano scale rely on engineered nanoparticles designed to package and deliver drugs to exactly where they’re needed.
Nanoparticles are a form of transport for drugs and can go places drugs wouldn't be able to go on their own. They make drug delivery more targeted, reducing collateral damage to healthy tissues.
In the early stage of Hodgkin’s Lymphoma the disease is curable in more than 90% of the cases.
The incidence of Hodgkin's lymphoma in Kenya isn't known, but new information is emerging to shed light on its prevalence.
Advances in breast cancer research in the last decade has introduced new treatment regimes.
The chances of surviving breast cancer are improving everyday due to advanced research and new treatment techniques.
Despite dozens of trials internationally, the evidence on medical cannabis is unconvincing.
NSW is about to embark on the largest and most definitive clinical trial ever of medicinal cannabis for chemotherapy-induced nausea and vomiting.
Cancer and its treatment can have a profound impact on the patient’s ability to work.
In Australia, there is no system in place to support people returning to work after cancer treatment – or to provide advice to their employers on how to help them.
Childhood cancer desperately needs more research.
Children's cancer is a rare disease, which means the market is small and pharmaceutical companies have few incentives to develop drugs for these cancers.
Mice that had only water before receiving chemotherapy, experienced less or no side effects compared to mice fed normally.
Research in animals and humans shows periods of fasting before and after chemotherapy protects healthy cells while killing cancerous ones more efficiently.
Humble hydrogels could one day replace hypodermic needles and repair damaged hearts.
Woman receiving chemotherapy.
New tools help doctors and breast cancer patients decide whether chemotherapy is needed. A recent study suggested that many can forgo chemo. But the decision is complicated. Here's why.
One in ten cancer patients can expect to face fertility issues after their treatment.
One in ten cancer patients will face fertility issues after treatment, but less than 50% are given options to preserve fertility. And those who are offered options can face significant cost barriers.
Cancer’s development and progression represent an evolutionary process.
Humans can more easily tolerate tumours in large or paired organs than in small, critical ones. This could be why the latter have evolved more cancer-fighting mechanisms.
Some cancer patients at St Vincent’s hospital were treated with off-protocol doses of a chemotherapy drug.
There is actually no existing evidence to show that a flat dose of 100mg of carboplatin provides inferior outcomes.
Glioblastomas are often resistant to the one type of drug that breaks the blood-brain barrier.
Glioblastoma is an aggressive form of brain cancer that has a very poor prognosis. Despite the current best therapies half its sufferers survive for 15 months and less than 5% are alive after 5 years.
Research shows some families pressure doctors to attempt heroic interventions on elderly relatives.
Javier Sánchez Salcedo/Flickr
We found one third of patients near the end of their life received non-beneficial treatments in hospitals around the world. These included initiating chemotherapy and providing emergency surgery.
Methotrexate is used for arthritis, psoriasis, inflammatory bowel disease and cancer.
Methotrexate is a drug used for rheumatoid arthritis, psoriasis and inflammatory bowel disease. It is taken on just one day a week. Accidental daily dosing can cause life-threatening toxicity.
We’ve come a long way since the 1950s in our understanding of breast cancer and how to treat it.
New research that more isn't better when it comes to chemotherapy mirrors the evolution of surgery approaches to breast cancer that, a few decades ago, were far more radical than now.
The cost of cancer drugs is killing patients and it needs to stop
Chemotherapy is used either to shrink cancers before surgery or to mop up cancer cells left behind after surgery.
Unlike most other types of drugs, the dose a chemotherapy patient is given isn't fixed. Instead it's individually selected based on height, weight and underlying health.
The best choice?
IV via www.shutterstock.com.
Research on IV devices is underdeveloped, underfunded and understudied. That means doctors don't always have the information they need to choose the best one for their patients.
This year marks the 50th anniversary of cisplatin’s accidental discovery as an anticancer drug.
Cancer drug cisplatin was accidentally discovered to help treat cancer in 1965. And it's been doing exactly that since it was approved for use in 1978.